Burcon NutraScience Corp (TSX:BU)

Q1 2027 Burcon NutraScience Corp Earnings Call Transcript

Aug 12, 2026 / 09:00 PM GMT

Release Date Price: C$1.86 (+3.33%)

Transcript

Key Points

Positve

Burcon NutraScience Corp (BRCNF) reported Q1 fiscal 2027 revenues of $1.3 million, a 54% sequential increase and a three-fold year-over-year growth, marking its eighth consecutive quarter of sequential revenue growth.
The company has surpassed 40 active buying customers, with repeat purchases validating its technology and demonstrating strong product-market fit across diverse food applications and customer types.
Burcon NutraScience Corp (BRCNF) reduced its operating loss by 7% quarter-over-quarter, showcasing improved operational efficiency and disciplined cost management while scaling production.
The company announced a convertible debenture offering of up to $8.1 million with significant insider participation, signaling strong internal confidence in its growth strategy and future prospects.
Management expects double-digit revenue by the end of the calendar year and a crossover to cash flow positivity within the same period, driven by a robust sales funnel and capacity expansion plans.
Burcon NutraScience Corp (BRCNF) benefits from a favorable macro environment, including rising consumer protein demand and the accelerating adoption of GLP-1 medications, which increases the need for high-protein, low-calorie food products.

Negative

Burcon NutraScience Corp (BRCNF) remains unprofitable, with ongoing operating losses despite revenue growth, indicating that the company has not yet achieved financial sustainability.
The company's growth is heavily dependent on executing capacity expansion investments, and any delays in scaling production could hinder its ability to meet anticipated customer demand.
Burcon NutraScience Corp (BRCNF) relies on a bridge loan to fund operations until the convertible debenture financing closes, exposing it to short-term liquidity and financing completion risks.
The company's revenue growth is expected to be back-end loaded, meaning near-term quarters may continue to show modest results, which could test investor patience.
Management acknowledged that the company is still in the 'first inning' of the GLP-1-driven protein market opportunity, implying that significant revenue contributions from this trend are still years away.
The company's focus is primarily on North America, and it lacks a clear strategy or qualified leadership to capitalize on international markets, potentially limiting its long-term growth potential.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BU.TO - Burcon NutraScience Corp
Q1 2027 Burcon NutraScience Corp Earnings Call
Aug 12, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon, everyone, and thank you for participating in today's conference call to discuss BIRCOM's NutraScience Corporation Fiscal 2027 First Quarter Conference Call. Joining us today are Kip Underwood, BIRCOM's Chief Executive Officer, and Alex Barti, the company's Interim Chief Financial Officer.

Following their presentation, we will open up the call for questions. To join the question queue, you may press star then one on your telephone keypad. Should you need assistance during the conference call, you may signal an operator by pressing star then zero.

Then before we conclude today's conference call, I'll provide you with the company's safe harbor statement with important cautions regarding the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.